Nuvation Bio Inc. (NUVB) Announces Exclusive Licensing Agreement With Eisai to Expand Global Reach of Taletrectinib

Nuvation Bio Inc. (NYSE:NUVB) is among the 14 champion booming stocks to bargain close now. On January 12, the oncology institution announced that it had entered into an exclusive licensing and collaboration statement with Eisai Co. Ltd. to grow the planetary scope of its lung crab pill.

Taletrectinib is presently approved for usage by patients with precocious ROS1-positive (ROS1+) non-small compartment lung crab (NSCLC) successful the United States, China, and Japan. However, the statement has present granted Eisai the rights to make and commercialize the cause for the attraction of the illness successful Europe, the Middle East, North Africa, India, and beyond successful respective different countries.

Nuvation Bio Inc. (NYSE:NUVB), successful a property release, said it would clasp afloat commercialization rights successful the United States to support its absorption connected activities successful the country. It volition besides pb planetary improvement and proceed to absorption connected ongoing probe studies.

In different news, connected the aforesaid day, the institution shared preliminary results for the 4th fourth and afloat twelvemonth 2025, with IBTROZI’s (taletrectinib) nett merchandise gross astatine $15.7 cardinal for the 4th quarter, bringing the full to $24.7 cardinal since its motorboat successful June past year.

Following the results, H.C. Wainwright lowered its terms people connected the banal to $17 from $18, portion maintaining a Buy rating. The steadfast noted that IBTROZI’s quarterly gross mostly came successful enactment with expectations.

Wall Street analysts person a statement Strong Buy standing connected the stock, with an mean stock terms people of $11.38, representing an upside of 76.16% arsenic of the adjacent connected January 12.

Nuvation Bio Inc. (NYSE:NUVB) is simply a biopharmaceutical institution focused connected the improvement of caller oncology therapies.

While we admit the imaginable of NUVB arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 14 Best S&P 500 Stocks to Buy Now and 11 Most Oversold S&P 500 Stocks Heading into 2026

Disclosure: None.